Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Cottin

Showing results (261-270 of 624) with videos related to

Pageof 63
Sort By:
The European Respiratory Journal|December 11, 2012
Selected clinical highlights from the 2012 ERS congress in ViennaMaurizio Marvisi, Felix J F Herth, Sebastian Ley, et al.
Frontiers in Medicine|July 5, 2022
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a <i>post-hoc</i> AnalysisMaria Molina-Molina, Michael Kreuter, Vincent Cottin, et al.
BMJ Open Respiratory Research|October 10, 2025
Use of supplemental oxygen therapy in idiopathic pulmonary fibrosis: an observational real-life study in 16 003 patientsClaire Marant-Micallef, Manon Belhassen, Jean-Michel Fourrier, et al.
Respiratory Research|June 19, 2026
Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study)Vincent Cottin, Marie Najean, Elise Arnee, et al.
Medicine|July 30, 2016
Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature reviewMathieu Gerfaud-Valentin, Vincent Cottin, Yvan Jamilloux, et al.
European Radiology|October 12, 2017
Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complicationsJohan Etievant, Salim Si-Mohamed, Nicolas Vinurel, et al.
Journal of Personalized Medicine|July 27, 2022
Embolization of Recurrent Pulmonary Arteriovenous Malformations by Ethylene Vinyl Alcohol Copolymer (Onyx<sup>®</sup>) in Hereditary Hemorrhagic Telangiectasia: Safety and EfficacySalim A Si-Mohamed, Alexandra Cierco, Delphine Gamondes, et al.
Advances in Therapy|December 22, 2021
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid UseMichael Kreuter, Toby M Maher, Tamera J Corte, et al.
ERJ Open Research|December 5, 2018
Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertensionMarylise Ginoux, Ségolène Turquier, Nader Chebib, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 13, 2002
Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosisGwendolyn S Kerby, Vincent Cottin, Frank J Accurso, et al.
Pageof 63

Showing results (261-270 of 624) with videos related to

Sort By:
Pageof 63
The European Respiratory Journal|December 11, 2012
Selected clinical highlights from the 2012 ERS congress in ViennaMaurizio Marvisi, Felix J F Herth, Sebastian Ley, et al.
Frontiers in Medicine|July 5, 2022
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a <i>post-hoc</i> AnalysisMaria Molina-Molina, Michael Kreuter, Vincent Cottin, et al.
BMJ Open Respiratory Research|October 10, 2025
Use of supplemental oxygen therapy in idiopathic pulmonary fibrosis: an observational real-life study in 16 003 patientsClaire Marant-Micallef, Manon Belhassen, Jean-Michel Fourrier, et al.
Respiratory Research|June 19, 2026
Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study)Vincent Cottin, Marie Najean, Elise Arnee, et al.
Medicine|July 30, 2016
Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature reviewMathieu Gerfaud-Valentin, Vincent Cottin, Yvan Jamilloux, et al.
European Radiology|October 12, 2017
Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complicationsJohan Etievant, Salim Si-Mohamed, Nicolas Vinurel, et al.
Journal of Personalized Medicine|July 27, 2022
Embolization of Recurrent Pulmonary Arteriovenous Malformations by Ethylene Vinyl Alcohol Copolymer (Onyx<sup>®</sup>) in Hereditary Hemorrhagic Telangiectasia: Safety and EfficacySalim A Si-Mohamed, Alexandra Cierco, Delphine Gamondes, et al.
Advances in Therapy|December 22, 2021
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid UseMichael Kreuter, Toby M Maher, Tamera J Corte, et al.
ERJ Open Research|December 5, 2018
Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertensionMarylise Ginoux, Ségolène Turquier, Nader Chebib, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 13, 2002
Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosisGwendolyn S Kerby, Vincent Cottin, Frank J Accurso, et al.
Pageof 63